1. Home
  2. Research
  3. Research Groups
  4. Surgical research in urology and renal trasplantation

Surgical research in urology and renal trasplantation

Search for publications

Only original articles, editorials, guidelines.

  • Aguzzi C, De Summa S, Molina-Cerrillo J, Alonso-Gordoa T, Nabissi M, Rizzo M, Zeppellini A, Sunela K, Sorgentoni G, Ortega C, Massari F, Marques Monteiro FS, Battelli N, Porta C, Santoni G, Santoni M.

    mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1a).

    Biochemistry and Biophysics Reports . 43: 102162-102162.

    [doi:10.1016/j.bbrep.2025.102162]

  • Schwartzmann I, Secco S, Farré A, García-Barreras S, Fernández E, D'Anna M, Cindolo L, Parejo V, Tornero JI, Ferrari G, Varvello F, Ponce de León J, Povo I.

    Injection density in Rezum®: Less might not be more. A multicentric international study.

    Actas Urologicas Espanolas . 49(7): 501824-501824.

    [doi:10.1016/j.acuroe.2025.501824]

  • Rubio-Briones J, Borque-Fernando A, Esteban Escaño LM, Wong A, Guijarro Cascales A, Gómez Gómez E, Gil Fabra JM, Sanguedolce F, Gomez-Veiga F, López González PA, Plata Bello A, Rodríguez García N, Montesino Semper M, Suárez Novo JF, Hajianfar R, Fumadó Ciutat LL, González Alfaro A, Duarte Ojeda JM, Bono Ariño A, Quicios Dorado C, Loizaga Iriarte A, García Fadrique G, Giménez Bachs JM, García Barreras S, Pallas Costa Y, Vilaseca Cabo A, Rodrigo Aliaga M, Campanario Pérez F, Servián P, Campá Bortoló JM, Soto Delgado M, Rodríguez de Ledesma JM, Sánchez Rodríguez C, Chantada Abal V, Hernández Martínez YE, Herrera Imbroda B, Dolezal P, Gual Frau J, Medrano Llorente P, Moreno Jiménez J, Serrano Uribe JS, Congregado Ruiz CB, Reyes A, Fernández Aparicio T, García Rodríguez J, Cuadras Solé M, García Seguí A, Pacheco Bru JJ, Mayor de Castro J, Mira Moreno A, Molina Suárez JL.

    Real World Evidence of Active Surveillance for Prostate Cancer in Spain; Midterm Results.

    CANCER MEDICINE . 14(17): .

    [doi:10.1002/cam4.71173]

  • Artiles Medina A, Tagalos Muñoz A, Domínguez Gutiérrez A, Muriel García A, Subiela JD, Álvarez Díaz N, Fernández Conejo G, Gómez Dos Santos V, Coloma Del Peso A, Burgos Revilla FJ.

    Outcomes of Active Treatment for Localised Prostate Cancer After Holmium Laser Enucleation of the Prostate: A Systematic Review and Meta-analysis.

    European Urology Open Science . 79: 111-127.

    [doi:10.1016/j.euros.2025.07.011]

  • Artiles Medina A, Bajawi Carretero M, López Pérez E, Garach Fernández S, López Curtis D, Elías Pascual L, Subiela JD, Soto Pérez-Olivares J, Nieto Góngora C, González Tello F, de la Parra Sánchez I, Mínguez Ojeda C, Gómez Dos Santos V, Burgos Revilla FJ.

    Impact of Preoperative CT-Diagnosed Sarcopenic Obesity on Outcomes After Radical Cystectomy for Bladder Cancer.

    Cancers . 17(16): .

    [doi:10.3390/cancers17162669]

  • Fernández-Conejo G, Subiela Henríquez JD, Tagalos Muñoz A, González Álvarez C, Fernández Mardomingo A, Sanz Mayayo E, Díez Nicolás V, García Barreras S, Gómez Dos Santos V, Rodríguez-Patrón R, Burgos Revilla FJ.

    Standardizing radical prostatectomy with the Versius robotic system: technical setup and early institutional experience.

    Journal of Robotic Surgery . 19(1): 470-470.

    [doi:10.1007/s11701-025-02639-0]

  • Lopez-Valcarcel M, Lopez-Campos F, Zafra-Martín J, Cienfuegos Belmonte I, Subiela JD, Ruiz-Vico M, Fernandez Alonso S, Garcia Cuesta JA, Couñago F.

    Biomarkers in Localized Prostate Cancer: From Diagnosis to Treatment.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 26(16): .

    [doi:10.3390/ijms26167667]

  • Jimenez-Fonseca P, Álvarez-Escola C, Ballester Navarro I, Hernando Cubero J, González Fernández L, Mangas Cruz MÁ, Iglesias C, García-Donas J, Picón MJ, Paja M, González Batanero L, García L, Molina J, Jimeno Maté R, Aller J, Romero MDCT, Cardenas Salas J, Gutiérrez-Buey G, Egaña Zunzunegui N, Navarro M, Lecumberri MJ, Valdés N, Carmona-Bayonas A.

    External validation of the S-GRAS score for predicting recurrence in patients with adrenocortical carcinoma: implications for adjuvant mitotane therapy.

    EUROPEAN JOURNAL OF ENDOCRINOLOGY . 193(2): 320-328.

    [doi:10.1093/ejendo/lvaf171]

  • Bourlon MT, Galli L, Grande E, Park SH, Melichar B, Schieber TJ, Juan-Fita MJ, Ürün Y, Molina-Cerrillo J, Alonso-Gordoa T, De Giorgi U, Kucharz J, Pérez Calabuig E, Conteduca V, Taha T, Rescigno P, Abu-Sini H, Spinelli GP, Manneh Kopp R, Salfi A, Bhuva D, Valdez-Sandoval P, Mendez-Bribiesca S, Fiala O, Buti S, Marques Monteiro FS, Bamias A, Ghosn M, Massari F, Ansari J, Santoni M.

    Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study.

    Frontiers in Oncology . 15: 1605282-1605282.

    [doi:10.3389/fonc.2025.1605282]

  • Manneh R, Molina-Cerrillo J, de Velasco G, Ibatá L, Martínez S, Ruiz-Granados Á, Alonso-Gordoa T.

    PARP Inhibitors for Metastatic CRPC: More Answers than Questions, a Systematic Review and Meta-Analysis.

    PHARMACEUTICALS . 18(7): .

    [doi:10.3390/ph18071015]

  • Rizzo M, Soares A, Gupta S, Calabrò F, Takeshita H, Bourlon MT, Park SH, Giannatempo P, Myint ZW, Büttner T, Grande E, Fiala O, Santini D, Bamias A, Zakopoulou R, Buti S, Kanesvaran R, Rescigno P, Molina-Cerrillo J, Epstein I, Marques Monteiro FS, Massari F, Porta C, Bellmunt J, Santoni M.

    Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.

    Jco Global Oncology . 11: .

    [doi:10.1200/GO-24-00564]

  • López Curtis DA, Artiles Medina A, Subiela JD, Fernández-Mardomingo Díaz A, González Tello F, Muriel García A, de la Parra Sánchez I, Mínguez Ojeda C, Jiménez Cidre MÁ, Gómez Dos Santos V, Burgos Revilla FJ.

    Revisiting angiomyolipomas: The significance of a rich blood supply on imaging for risk-adapted decision making.

    Investigative and Clinical Urology . 66(4): 285-294.

    [doi:10.4111/icu.20250059]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Slusarczyk A, Soria F, Pradere B, Krajewski W, D'Andrea D, Mari A, Del Giudice F, Pichler R, Subiela JD, Marcq G, Gallioli A, Afferi L, Mastroianni R, Simone G, Albisinni S, Mertens LS, Laukhtina E, Oberneder K, Rodríguez Elena JL, Aranda J, Puentedura AL, Caño Velasco J, Contieri R, Hurle R, Mori K, Radziszewski P, Shariat SF, Gontero P, Necchi A, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Outcomes of BCG vs upfront radical cystectomy for high-risk non-muscle-invasive bladder cancer.

    BJU INTERNATIONAL . 136(1): 47-54.

    [doi:10.1111/bju.16675]

  • Carnero-Alcázar M, Nuñez-Gil IJ, Vilacosta I, Montero L, Cuerpo G, Lopez-Menendez J, Feltes-Guzman G, Beltrao-Sial R, Pérez-Camargo D, Vicedo-López Á, Miranda-Torrón J, Solís-Chávez MB, Cobiella J, Maroto L.

    Need for a permanent pacemaker after transcatheter aortic valve implantation in Spain: a retrospective analysis of the national Minimum Basic Dataset from 2017 to 2022.

    Open Heart . 12(1): .

    [doi:10.1136/openhrt-2025-003396]

  • Pichler R, van Creij NCH, Subiela JD, Cimadamore A, Caño-Velasco J, Tully KH, Mori K, Contieri R, Afferi L, Mari A, Soria F, Del Giudice F, D'Elia C, Mayr R, Mertens LS, Pyrgidis N, Moschini M, Gallioli A.

    Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease.

    Actas Urologicas Espanolas . 49(5): 501719-501719.

    [doi:10.1016/j.acuroe.2025.501719]

  • Scilipoti P, Longoni M, de Angelis M, Zaurito P, Massiet A, Dutto D, Soria F, Álvarez-Maestro M, Bazán AA, Pradere B, Klatte T, Contieri R, Hurle R, Krajewski W, Subiela JD, Pichler R, Szostek A, Marcq G, Elena JLR, Aranda J, Gontero P, Rouprêt M, Shariat SF, Necchi A, Montorsi F, Briganti A, Xylinas E, Moschini M.

    Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results.

    BJU INTERNATIONAL . 135(6): 969-976.

    [doi:10.1111/bju.16645]

  • Albers Acosta E, Pelari-Mici L, Celada Luis G, Velasco Balanza C, Zapatero A, Romero-Laorden N, Toquero Diez P, Caño-Velasco J, Guerrero-Ramos F, Moschini M, Krajewski W, Del Giudice F, Soria F, Laukhtina E, Mertens L, Pichler R, Mori K, D'Andrea D, Mari A, Marcq G, Teoh J, Afferi L, Albisinni S, Pradere B, Gallioli A, Subiela JD, San José Manso L.

    The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review.

    Actas Urologicas Espanolas . 49(5): 501718-501718.

    [doi:10.1016/j.acuroe.2025.501718]

  • Santoni M, Roviello G, Grande E, De Giorgi U, Fiala O, Seront E, Molina-Cerrillo J, Pichler R, Myint ZW, Kucharz J, Kanesvaran R, Büttner T, Pichler M, Basso U, Kopecky J, Bourlon MT, Cerbone L, Buchler T, Pinto A, de Liaño AG, Gianni C, Zgura A, Rescigno P, Ansari J, Caffo O, Küronya Z, Vitale MG, Bhuva D, Catalano M, Vau N, Kopp RM, Buti S, Bamias A, Porta C, Sunela K, Massari F.

    Pembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1).

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 74(7): 225-225.

    [doi:10.1007/s00262-025-04043-x]